Atlas Trials

A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)

Clinical trial NCT02786407 · UNKNOWN

Trial details

NCT number
NCT02786407
Sponsor
Lanzhou Institute of Biological Products Co., Ltd
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Overactive Bladder
Start date
2016-03-01
Primary completion
2018-11-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.